Back

Elevated factor XI is associated with left atrial appendage thrombi of unknown origin: links to unfavorable fibrin clot properties

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms and molecular insights into thrombosis and thromboinflammation Thrombosis, Bleeding ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Szymon Glanowski

Krakow (Poland)

7 More presentations in this session

Presentation thumbnail
Single-cell multiomics of human thrombosis reveals immunothrombolytic monocyte-neutrophil interactions and hypoxia-driven thrombus resolution
Doctor K. Stark (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Plasma proteome dynamics in venous thromboembolism
Doctor M. Iglesias (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Unravelling the auspicious role of interleukin-6 in acute deep vein thrombosis: intravital and postmortem insights
Doctor A. Achyar (Yogyakarta, ID)
Abstract Slides Video
Presentation thumbnail
Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction
Doctor K. Mroz (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Sex- and age-specific transcriptomic changes drive the prothrombotic potential of megakaryocytes
Ms A. Seeberger (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms and molecular insights into thrombosis and thromboinflammation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
What does the future hold for factor XIa vs. factor Xa inhibitors in atrial fibrillation, acute coronary syndrome and stroke?
thumbnail
Congress Presentation
The levels of FXI are associated with altered fibrin clot properties and thrombin generation in patients with acute decompensated HFrEF and sinus rhythm: a preliminary study.
thumbnail
Congress Session
Advances in thrombosis management: evaluating current and emerging anticoagulation strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources